Table 5 Risk of fracture considering exposure to renin-angiotensin system inhibitors in subgroups
Variables | Fracture case | Controls | Conditional logistic regression | ||||
|---|---|---|---|---|---|---|---|
(n = 1,049) | (n = 1,049) | ||||||
n | % | n | % | OR (95% CI) | P-value | ||
Diabetes | Never-user | 215 | 52.7 | 193 | 47.3 | ||
Ever-user | 135 | 47.5 | 149 | 52.5 | 0.81 (0.49–1.35) | 0.415 | |
No diabetes | Never-user | 604 | 50.8 | 585 | 49.2 | ||
Ever-user | 95 | 43.8 | 122 | 56.2 | 0.74 (0.51–1.07) | 0.108 | |
No stroke | Never-user | 811 | 51.2 | 773 | 48.8 | ||
Ever-user | 223 | 45.7 | 265 | 54.3 | 0.73 (0.58–0.91) | 0.005 | |
BMI ≥ 23 kg/m2 | Never-user | 427 | 51.9 | 396 | 48.1 | ||
Ever-user | 159 | 45.8 | 188 | 54.2 | 0.65 (0.46–0.91) | 0.013 | |
Statins | Never-user | 66 | 50.8 | 64 | 49.2 | ||
Ever-user | 92 | 48.4 | 98 | 51.6 | 0.62 (0.47–0.83) | 0.001 | |
No statins | Never-user | 392 | 50.6 | 382 | 49.4 | ||
Ever-user | 71 | 46.1 | 83 | 53.9 | 0.61 (0.35–1.05) | 0.074 | |